“…The SAR revealed that the linker between the fluoroquinolone and nalidixic acid has great influence on the activity, and hybrids 23b,d with 1,2,4‐triazole‐5(4 H )‐thione as linker were inactive against C. albicans and S. cerevisiae . The sparfloxacin derivatives 24a–c not only showed promising antibacterial activity against a range of Gram‐positive and Gram‐negative pathogens which were comparable to the parent sparfloxacin, but also exhibited considerable antifungal against Fusarium solani , Trichophyton rubrum , Aspergillus parasiticus , C. albicans , and A. effuses , suggesting that the sparfloxacin derivatives 24a–c were more potent than the references sparfloxacin, gatifloxacin, and gemifloxacin against most fungi . However, the norfloxacin‐/ciprofloxacin‐benzimidazole hybrids 25 were inactive against A. niger , R. nigricans , and C. albicans at the concentration of 50 μg/ml…”